BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 34623320)

  • 1. T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling.
    Marchelletta RR; Krishnan M; Spalinger MR; Placone TW; Alvarez R; Sayoc-Becerra A; Canale V; Shawki A; Park YS; Bernts LH; Myers S; Tremblay ML; Barrett KE; Krystofiak E; Kachar B; McGovern DP; Weber CR; Hanson EM; Eckmann L; McCole DF
    J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells.
    Krishnan M; McCole DF
    Ann N Y Acad Sci; 2017 Oct; 1405(1):116-130. PubMed ID: 28804910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.
    Spalinger MR; Sayoc-Becerra A; Santos AN; Shawki A; Canale V; Krishnan M; Niechcial A; Obialo N; Scharl M; Li J; Nair MG; McCole DF
    Gastroenterology; 2020 Nov; 159(5):1763-1777.e14. PubMed ID: 32652144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier Defects.
    Krishnan M; Penrose HM; Shah NN; Marchelletta RR; McCole DF
    Inflamm Bowel Dis; 2016 Dec; 22(12):2811-2823. PubMed ID: 27824650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of epithelial barrier function by the inflammatory bowel disease candidate gene, PTPN2.
    McCole DF
    Ann N Y Acad Sci; 2012 Jun; 1257():108-14. PubMed ID: 22671596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN2 mutations cause epithelium-intrinsic barrier loss that synergizes with mucosal immune hyperactivation.
    Sweat YY; Turner JR
    J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spermidine stimulates T cell protein-tyrosine phosphatase-mediated protection of intestinal epithelial barrier function.
    Penrose HM; Marchelletta RR; Krishnan M; McCole DF
    J Biol Chem; 2013 Nov; 288(45):32651-32662. PubMed ID: 24022492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1.
    Fischer A; Gluth M; Weege F; Pape UF; Wiedenmann B; Baumgart DC; Theuring F
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G218-28. PubMed ID: 24309183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Sayoc-Becerra A; Krishnan M; Fan S; Jimenez J; Hernandez R; Gibson K; Preciado R; Butt G; McCole DF
    Inflamm Bowel Dis; 2020 Feb; 26(3):407-422. PubMed ID: 31751457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.
    Spalinger MR; Sayoc-Becerra A; Ordookhanian C; Canale V; Santos AN; King SJ; Krishnan M; Nair MG; Scharl M; McCole DF
    J Crohns Colitis; 2021 Mar; 15(3):471-484. PubMed ID: 32909045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.
    Spalinger MR; McCole DF; Rogler G; Scharl M
    World J Gastroenterol; 2016 Jan; 22(3):1034-44. PubMed ID: 26811645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2.
    Scharl M; Paul G; Weber A; Jung BC; Docherty MJ; Hausmann M; Rogler G; Barrett KE; McCole DF
    Gastroenterology; 2009 Dec; 137(6):2030-2040.e5. PubMed ID: 19818778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease.
    Cheng Y; Hall TR; Xu X; Yung I; Souza D; Zheng J; Schiele F; Hoffmann M; Mbow ML; Garnett JP; Li J
    EBioMedicine; 2022 Jan; 75():103758. PubMed ID: 34933179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.
    Mennigen R; Nolte K; Rijcken E; Utech M; Loeffler B; Senninger N; Bruewer M
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1140-9. PubMed ID: 19221015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role for protein tyrosine phosphatase nonreceptor type 2 in regulating autophagosome formation.
    Scharl M; Rogler G
    Ann N Y Acad Sci; 2012 Jun; 1257():93-102. PubMed ID: 22671594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy Reduces the Degradation and Promotes Membrane Localization of Occludin to Enhance the Intestinal Epithelial Tight Junction Barrier against Paracellular Macromolecule Flux.
    Saha K; Subramenium Ganapathy A; Wang A; Michael Morris N; Suchanec E; Ding W; Yochum G; Koltun W; Nighot M; Ma T; Nighot P
    J Crohns Colitis; 2023 Apr; 17(3):433-449. PubMed ID: 36219473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases.
    Barmeyer C; Fromm M; Schulzke JD
    Pflugers Arch; 2017 Jan; 469(1):15-26. PubMed ID: 27904960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of PTPN2 SNP rs1893217 Enhances the Anti-inflammatory Effect of Spermidine.
    Niechcial A; Butter M; Manz S; Obialo N; Bäbler K; van der Lely L; Lang S; Gottier C; McCole DF; Scharl M; Spalinger MR
    Inflamm Bowel Dis; 2020 Jun; 26(7):1038-1049. PubMed ID: 32031616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.
    Zeissig S; Bürgel N; Günzel D; Richter J; Mankertz J; Wahnschaffe U; Kroesen AJ; Zeitz M; Fromm M; Schulzke JD
    Gut; 2007 Jan; 56(1):61-72. PubMed ID: 16822808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.